January 12, 2024 | BALTIMORE – Complete Omics’ Clinical Proteomics team are thrilled to announce that Dr. Hui Zhang, a distinguished figure in the realm of proteomics, has joined the Complete Omics family as our Chief Scientific Officer (CSO) and Director for the Center for Advanced Proteomics. Dr. Zhang, a founding member of the Clinical Proteomic Tumor Analysis Consortium (CPTAC), brings to our team a rich legacy of innovation and leadership in proteomics, especially known for her pioneering work in multi-omics studies on human cancers and her revolutionary innovation on the methods in studying N-Glycosylation on proteins.
Collaboration with Columbia University
Mar 30, 2022 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Kam W. Leong, Samuel Y. Sheng professor of Biomedical Engineering, and his team from Columbia University on a clinical proteomics project focusing on leveraging our Complete360 quantitative proteomics assays for clinical discoveries.
Collaboration with Tel Aviv University
Mar 20, 2022 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Miguel Weil from Department of Cell Research and Immunology at the Tel Aviv University on a clinical proteomics project focusing on leveraging our Complete360 body fluid proteomics assays for clinical discoveries.
Collaboration with Lisbon School of Medicine
Feb 26, 2022 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Luis Marques da Costa and his team from Lisbon School of Medicine on a clinical proteomics project focusing on leveraging our Complete360 body fluid proteomics assays for clinical discoveries.